ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,856.45
0.90%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. CytoSorbents Corporation (CTSO)

  7. CytoSorbents Corporation (CTSO) News

CytoSorbents (CTSO)

CytoSorbents Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CTSO
DateTimeSourceHeadlineSymbolCompany
24/06/202412:00GlobeNewswire Inc.CytoSorbents Announces Regulatory Approval of CytoSorb® in TaiwanNASDAQ:CTSOCytoSorbents Corporation
13/06/202412:00GlobeNewswire Inc.CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European UnionNASDAQ:CTSOCytoSorbents Corporation
10/06/202421:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
05/06/202412:00GlobeNewswire Inc.CytoSorbents to Host its 2024 Virtual Annual Stockholders MeetingNASDAQ:CTSOCytoSorbents Corporation
22/05/202421:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
09/05/202422:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
09/05/202421:17GlobeNewswire Inc.CytoSorbents Reports First Quarter 2024 ResultsNASDAQ:CTSOCytoSorbents Corporation
09/05/202421:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTSOCytoSorbents Corporation
06/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
02/05/202412:00GlobeNewswire Inc.CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in EuropeNASDAQ:CTSOCytoSorbents Corporation
26/04/202412:00GlobeNewswire Inc.CytoSorbents to Report First Quarter 2024 Operating and Financial ResultsNASDAQ:CTSOCytoSorbents Corporation
17/04/202412:00GlobeNewswire Inc.STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual MeetingNASDAQ:CTSOCytoSorbents Corporation
06/03/202412:00GlobeNewswire Inc.CytoSorbents to Report Fiscal 2023 Operating and Financial ResultsNASDAQ:CTSOCytoSorbents Corporation
08/02/202412:00GlobeNewswire Inc.CytoSorbents to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:CTSOCytoSorbents Corporation
17/01/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
17/01/202412:15GlobeNewswire Inc.Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant PatientsNASDAQ:CTSOCytoSorbents Corporation
08/01/202420:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CTSOCytoSorbents Corporation
28/12/202321:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
28/12/202312:00GlobeNewswire Inc.CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board RecommendationNASDAQ:CTSOCytoSorbents Corporation
15/12/202321:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
15/12/202321:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
15/12/202321:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
15/12/202321:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
15/12/202321:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
15/12/202321:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
15/12/202321:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
15/12/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
13/12/202314:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
13/12/202314:15GlobeNewswire Inc.CytoSorbents Announces Closing of $10.3 Million Registered Direct OfferingNASDAQ:CTSOCytoSorbents Corporation
11/12/202321:10Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CTSOCytoSorbents Corporation
 Showing the most relevant articles for your search:NASDAQ:CTSO

Your Recent History

LSE
BP.
Bp
LSE
SCE
Surface Transforms
LSE
TERN
Tern
LSE
LLOY
Lloyds Banking
LSE
ENET
Ethernity Networks
LSE
ALTN
Altyngold
LSE
VAST
Vast Resources
LSE
SYME
Supply@me Capital
LSE
PANR
Pantheon Resources
LSE
QBT
Quantum Blockchain Techn...
LSE
DEC
Diversified Energy
LSE
IES
Invinity Energy Systems
LSE
GKP
Gulf Keystone Petroleum
LSE
BCE
Beacon Energy
LSE
POS
Plexus
LSE
UKOG
Uk Oil & Gas
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved